The retention indices of 201Tl-SPECT in brain tumors

Annals of Nuclear Medicine

Volumn 16, Issue 7, 2002, Pages 455-459

  Otsuka, Hideki ^a,b   Shinbata, Hiroyuki ^a   Hieda, Masashi ^a   Yamashita, Kyo ^a   Kitamura, Hiroki ^a   Senba, Takatoshi ^a   Kashihara, Kenichi ^a   Tagashira, Hiroshi ^a  

^a EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

201T1 SPECT; Brain tumor; Gd enhanced MRI; Retention index

Indexed keywords

GADOLINIUM; THALLIUM 201; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; THALLIUM; THALLIUM CHLORIDE;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BRAIN TUMOR; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG RETENTION; EQUIPMENT; FEMALE; GLIOMA; HISTOLOGY; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ADOLESCENT; CHILD; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; THALLIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036866570     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02988641     Document Type: Article

References (13)

1. Derebek E, Biberoglu S, Kut O, Yesil S, Saydam S, Yilmaz M, et al. Early and delayed thallium-201 scintigraphy in thyroid nodules: The relationship between early thallium-201 uptake and perfusion. Eur J Nucl Med 1996; 23: 504-510.
2. Sato O, Kawai A, Ozaki T, Kunisada T, Danura T, Inoue H. Value of thallium-201 scintigraphy in bone and soft tissue tumors. J Orthop Sci 1998; 3: 297-303.
3. m-MIBI SPET. Nucl Med Commun 2001; 22: 539-545.
4. Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System. 2nd Edn. Berlin; Springer-Verlag, 1993.
5. 201Tl indices in brain turnouts. Nucl Med Commun 1999; 20: 1023-1029.
6. Gungor F, Bezircioglu H, Guvenc G, Tezcan A, Yildiz A, Uluc E, et al. Correlation of thallium-201 uptake with proliferating cell nuclear antigen in brain tumours. Nucl Med Commun 2000; 21: 803-810.
7. + ATPase activities. KAKU IGAKU (Jpn J Nucl Med) 2000; 37: 311-318.
8. 201Tl SPET in the differential diagnosis of brain tumours. Nucl Med Commun 1999; 20: 637-645.
9. Hirano T, Otake H, Kazama K, Wakabayashi K, Zama A, Shibasaki T, et al. Technetium-99m(V)-DMSA and thallium-201 in brain tumor imaging: Correlation with histology and malignant grade. J Nucl Med 1997; 38: 1741-1749.
10. Lorberboym M, Wallach F, Estok L, Mosesson RE, Sacher M, Kim CK, et al. Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients. J Nucl Med 1998; 39: 1336-1369.
11. 201Tl SPET imaging in the follow-up of treatment for brain tumour: A sensitive tool for the early identification of response to chemothrapy? Nucl Med Commun 2000; 21: 259-267.
12. Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, et al. Posttherapeutic intraaxial brain tumor: The value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. Am J Neuroradiol 2000; 21: 901-909.
13. 201Tl single photon emission tomography in the evaluation of residual and recurrent astrocytoma. Nucl Med Commun 1994; 15: 140-143.